Summary

The global Traditional Chinese Medicine Injection market size is predicted to grow from US$ 6029 million in 2025 to US$ 7783 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.
Traditional Chinese Medicine Injections (TCMIs) are sterile preparations derived from traditional Chinese medicinal ingredients through processes such as extraction, purification, and formulation. Unique to China, TCMIs play an important role in treating severe or acute conditions, particularly when oral administration is not feasible. However, concerns over their complex composition and unclear pharmacological mechanisms have led to ongoing debates regarding their safety and efficacy. In recent years, strengthened regulatory oversight and post-market evaluation efforts have been driving the TCMI market toward higher standards and more regulated development.
The market for Traditional Chinese Medicine Injections (TCMIs) is undergoing a critical phase of adjustment and restructuring. With increasingly stringent regulatory oversight on safety, efficacy, and quality control, many products lacking sufficient clinical evidence have been phased out. As a result, market concentration has increased, and leading pharmaceutical companies are gaining stronger competitive advantages. At the same time, national procurement policies, which initially targeted oral formulations, are now extending to injections, subjecting TCMIs to greater pricing pressure and stricter access requirements. This shift is pushing companies to pivot from relying on distribution networks to focusing on clinical value and product strength.
Looking forward, the development of TCMIs is moving toward greater standardization, evidence-based practices, and product differentiation. Regulatory authorities are expected to continue promoting post-market clinical re-evaluation and higher quality standards, urging companies to generate more robust data on efficacy and safety. Meanwhile, some enterprises are exploring targeted therapies based on precision medicine principles, aiming to match specific TCMIs to defined diseases or patient groups. As reimbursement policies become moderately more flexible, there is potential for evidence-supported TCMIs to regain market access. Overall, the industry is progressing toward a path of high-quality growth.
The driving forces behind TCMI development are multifaceted. Their unique therapeutic value in certain clinical settings remains irreplaceable, and regulatory initiatives are encouraging enterprises to strengthen research and quality systems. However, several challenges persist. These include insufficient clinical evidence, public concerns about safety, policy-driven market volatility, and a lack of R&D commitment from some companies. Whether the sector can achieve sustainable, high-quality development will depend on the coordinated efforts of industry and regulators in scientific research, clinical validation, and standard-setting.
LP Information, Inc. (LPI) ' newest research report, the “Traditional Chinese Medicine Injection Industry Forecast” looks at past sales and reviews total world Traditional Chinese Medicine Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Traditional Chinese Medicine Injection sales for 2026 through 2032. With Traditional Chinese Medicine Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Traditional Chinese Medicine Injection industry.
This Insight Report provides a comprehensive analysis of the global Traditional Chinese Medicine Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Traditional Chinese Medicine Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Traditional Chinese Medicine Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Traditional Chinese Medicine Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Traditional Chinese Medicine Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Traditional Chinese Medicine Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Detoxification
Cardiovascular Disease Medication
Cerebrovascular Disease Medication
Anti-tumor Drugs
Other
Segmentation by Application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Green Valley Pharma
Changbaishan Pharmaceutical
Jemincare
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Kanion Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Linbao Pharmaceutical
Shineway Pharmaceutical
Shanghai Kaibao Pharmaceutical
Shanxi Zhendong Pharmaceutical
Mudanjiang Youbo Pharmaceutical
Xi'an Shijishengkang Pharmaceutical
China Resources Sanjiu Medical & Pharmaceutical
Tasly Pharmaceuticals
Dali Pharmaceutical
CONBA
Yunnan Biovalley Pharmaceutical
Shanghai Pharmaceuticals Holding
Jilin Jian Yisheng Pharmaceutical
Guizhou Yibai Pharmaceutical
CSPC Pharmaceutical Group
Yabao Pharmaceutical
Kunming Longjin Pharmaceutical
Yunnan Baiyao
Key Questions Addressed in this Report
What is the 10-year outlook for the global Traditional Chinese Medicine Injection market?
What factors are driving Traditional Chinese Medicine Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Traditional Chinese Medicine Injection market opportunities vary by end market size?
How does Traditional Chinese Medicine Injection break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Traditional Chinese Medicine Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Traditional Chinese Medicine Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Traditional Chinese Medicine Injection by Country/Region, 2021, 2025 & 2032
2.2 Traditional Chinese Medicine Injection Segment by Type
2.2.1 Detoxification
2.2.2 Cardiovascular Disease Medication
2.2.3 Cerebrovascular Disease Medication
2.2.4 Anti-tumor Drugs
2.2.5 Other
2.2.6 Traditional Chinese Medicine Injection Sales by Type
2.2.6.1 Global Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
2.2.6.2 Global Traditional Chinese Medicine Injection Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Traditional Chinese Medicine Injection Sale Price by Type (2021-2026)
2.3 Traditional Chinese Medicine Injection Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Traditional Chinese Medicine Injection Sales by Application
2.3.3.1 Global Traditional Chinese Medicine Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Traditional Chinese Medicine Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Traditional Chinese Medicine Injection Sale Price by Application (2021-2026)

3 Global by Company
3.1 Global Traditional Chinese Medicine Injection Breakdown Data by Company
3.1.1 Global Traditional Chinese Medicine Injection Annual Sales by Company (2021-2026)
3.1.2 Global Traditional Chinese Medicine Injection Sales Market Share by Company (2021-2026)
3.2 Global Traditional Chinese Medicine Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Traditional Chinese Medicine Injection Revenue by Company (2021-2026)
3.2.2 Global Traditional Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
3.3 Global Traditional Chinese Medicine Injection Sale Price by Company
3.4 Key Manufacturers Traditional Chinese Medicine Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Traditional Chinese Medicine Injection Product Location Distribution
3.4.2 Players Traditional Chinese Medicine Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 World Historic Review for Traditional Chinese Medicine Injection by Geographic Region
4.1 World Historic Traditional Chinese Medicine Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Traditional Chinese Medicine Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Traditional Chinese Medicine Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Traditional Chinese Medicine Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Traditional Chinese Medicine Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Traditional Chinese Medicine Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Traditional Chinese Medicine Injection Sales Growth
4.4 APAC Traditional Chinese Medicine Injection Sales Growth
4.5 Europe Traditional Chinese Medicine Injection Sales Growth
4.6 Middle East & Africa Traditional Chinese Medicine Injection Sales Growth

5 Americas
5.1 Americas Traditional Chinese Medicine Injection Sales by Country
5.1.1 Americas Traditional Chinese Medicine Injection Sales by Country (2021-2026)
5.1.2 Americas Traditional Chinese Medicine Injection Revenue by Country (2021-2026)
5.2 Americas Traditional Chinese Medicine Injection Sales by Type (2021-2026)
5.3 Americas Traditional Chinese Medicine Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Traditional Chinese Medicine Injection Sales by Region
6.1.1 APAC Traditional Chinese Medicine Injection Sales by Region (2021-2026)
6.1.2 APAC Traditional Chinese Medicine Injection Revenue by Region (2021-2026)
6.2 APAC Traditional Chinese Medicine Injection Sales by Type (2021-2026)
6.3 APAC Traditional Chinese Medicine Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe Traditional Chinese Medicine Injection by Country
7.1.1 Europe Traditional Chinese Medicine Injection Sales by Country (2021-2026)
7.1.2 Europe Traditional Chinese Medicine Injection Revenue by Country (2021-2026)
7.2 Europe Traditional Chinese Medicine Injection Sales by Type (2021-2026)
7.3 Europe Traditional Chinese Medicine Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Traditional Chinese Medicine Injection by Country
8.1.1 Middle East & Africa Traditional Chinese Medicine Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Traditional Chinese Medicine Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Traditional Chinese Medicine Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Traditional Chinese Medicine Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Traditional Chinese Medicine Injection
10.3 Manufacturing Process Analysis of Traditional Chinese Medicine Injection
10.4 Industry Chain Structure of Traditional Chinese Medicine Injection

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Traditional Chinese Medicine Injection Distributors
11.3 Traditional Chinese Medicine Injection Customer

12 World Forecast Review for Traditional Chinese Medicine Injection by Geographic Region
12.1 Global Traditional Chinese Medicine Injection Market Size Forecast by Region
12.1.1 Global Traditional Chinese Medicine Injection Forecast by Region (2027-2032)
12.1.2 Global Traditional Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Traditional Chinese Medicine Injection Forecast by Type (2027-2032)
12.7 Global Traditional Chinese Medicine Injection Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 Green Valley Pharma
13.1.1 Green Valley Pharma Company Information
13.1.2 Green Valley Pharma Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.1.3 Green Valley Pharma Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Green Valley Pharma Main Business Overview
13.1.5 Green Valley Pharma Latest Developments
13.2 Changbaishan Pharmaceutical
13.2.1 Changbaishan Pharmaceutical Company Information
13.2.2 Changbaishan Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.2.3 Changbaishan Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Changbaishan Pharmaceutical Main Business Overview
13.2.5 Changbaishan Pharmaceutical Latest Developments
13.3 Jemincare
13.3.1 Jemincare Company Information
13.3.2 Jemincare Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.3.3 Jemincare Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jemincare Main Business Overview
13.3.5 Jemincare Latest Developments
13.4 Qingfeng Pharmaceutical Group
13.4.1 Qingfeng Pharmaceutical Group Company Information
13.4.2 Qingfeng Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.4.3 Qingfeng Pharmaceutical Group Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Qingfeng Pharmaceutical Group Main Business Overview
13.4.5 Qingfeng Pharmaceutical Group Latest Developments
13.5 Buchang Pharmaceutical
13.5.1 Buchang Pharmaceutical Company Information
13.5.2 Buchang Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.5.3 Buchang Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Buchang Pharmaceutical Main Business Overview
13.5.5 Buchang Pharmaceutical Latest Developments
13.6 Livzon
13.6.1 Livzon Company Information
13.6.2 Livzon Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.6.3 Livzon Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Livzon Main Business Overview
13.6.5 Livzon Latest Developments
13.7 ZBD Pharmaceutical
13.7.1 ZBD Pharmaceutical Company Information
13.7.2 ZBD Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.7.3 ZBD Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ZBD Pharmaceutical Main Business Overview
13.7.5 ZBD Pharmaceutical Latest Developments
13.8 Chase Sun Pharmaceutical
13.8.1 Chase Sun Pharmaceutical Company Information
13.8.2 Chase Sun Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.8.3 Chase Sun Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chase Sun Pharmaceutical Main Business Overview
13.8.5 Chase Sun Pharmaceutical Latest Developments
13.9 Wuzhou Pharmaceutical
13.9.1 Wuzhou Pharmaceutical Company Information
13.9.2 Wuzhou Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.9.3 Wuzhou Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Wuzhou Pharmaceutical Main Business Overview
13.9.5 Wuzhou Pharmaceutical Latest Developments
13.10 Kanion Pharmaceutical
13.10.1 Kanion Pharmaceutical Company Information
13.10.2 Kanion Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.10.3 Kanion Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Kanion Pharmaceutical Main Business Overview
13.10.5 Kanion Pharmaceutical Latest Developments
13.11 Harbin Pharmaceutical Group
13.11.1 Harbin Pharmaceutical Group Company Information
13.11.2 Harbin Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.11.3 Harbin Pharmaceutical Group Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Harbin Pharmaceutical Group Main Business Overview
13.11.5 Harbin Pharmaceutical Group Latest Developments
13.12 Fusen Pharmaceutical
13.12.1 Fusen Pharmaceutical Company Information
13.12.2 Fusen Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.12.3 Fusen Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Fusen Pharmaceutical Main Business Overview
13.12.5 Fusen Pharmaceutical Latest Developments
13.13 Linbao Pharmaceutical
13.13.1 Linbao Pharmaceutical Company Information
13.13.2 Linbao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.13.3 Linbao Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Linbao Pharmaceutical Main Business Overview
13.13.5 Linbao Pharmaceutical Latest Developments
13.14 Shineway Pharmaceutical
13.14.1 Shineway Pharmaceutical Company Information
13.14.2 Shineway Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.14.3 Shineway Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shineway Pharmaceutical Main Business Overview
13.14.5 Shineway Pharmaceutical Latest Developments
13.15 Shanghai Kaibao Pharmaceutical
13.15.1 Shanghai Kaibao Pharmaceutical Company Information
13.15.2 Shanghai Kaibao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.15.3 Shanghai Kaibao Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Kaibao Pharmaceutical Main Business Overview
13.15.5 Shanghai Kaibao Pharmaceutical Latest Developments
13.16 Shanxi Zhendong Pharmaceutical
13.16.1 Shanxi Zhendong Pharmaceutical Company Information
13.16.2 Shanxi Zhendong Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.16.3 Shanxi Zhendong Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Shanxi Zhendong Pharmaceutical Main Business Overview
13.16.5 Shanxi Zhendong Pharmaceutical Latest Developments
13.17 Mudanjiang Youbo Pharmaceutical
13.17.1 Mudanjiang Youbo Pharmaceutical Company Information
13.17.2 Mudanjiang Youbo Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.17.3 Mudanjiang Youbo Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Mudanjiang Youbo Pharmaceutical Main Business Overview
13.17.5 Mudanjiang Youbo Pharmaceutical Latest Developments
13.18 Xi'an Shijishengkang Pharmaceutical
13.18.1 Xi'an Shijishengkang Pharmaceutical Company Information
13.18.2 Xi'an Shijishengkang Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.18.3 Xi'an Shijishengkang Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Xi'an Shijishengkang Pharmaceutical Main Business Overview
13.18.5 Xi'an Shijishengkang Pharmaceutical Latest Developments
13.19 China Resources Sanjiu Medical & Pharmaceutical
13.19.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
13.19.2 China Resources Sanjiu Medical & Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.19.3 China Resources Sanjiu Medical & Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 China Resources Sanjiu Medical & Pharmaceutical Main Business Overview
13.19.5 China Resources Sanjiu Medical & Pharmaceutical Latest Developments
13.20 Tasly Pharmaceuticals
13.20.1 Tasly Pharmaceuticals Company Information
13.20.2 Tasly Pharmaceuticals Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.20.3 Tasly Pharmaceuticals Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Tasly Pharmaceuticals Main Business Overview
13.20.5 Tasly Pharmaceuticals Latest Developments
13.21 Dali Pharmaceutical
13.21.1 Dali Pharmaceutical Company Information
13.21.2 Dali Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.21.3 Dali Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Dali Pharmaceutical Main Business Overview
13.21.5 Dali Pharmaceutical Latest Developments
13.22 CONBA
13.22.1 CONBA Company Information
13.22.2 CONBA Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.22.3 CONBA Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 CONBA Main Business Overview
13.22.5 CONBA Latest Developments
13.23 Yunnan Biovalley Pharmaceutical
13.23.1 Yunnan Biovalley Pharmaceutical Company Information
13.23.2 Yunnan Biovalley Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.23.3 Yunnan Biovalley Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Yunnan Biovalley Pharmaceutical Main Business Overview
13.23.5 Yunnan Biovalley Pharmaceutical Latest Developments
13.24 Shanghai Pharmaceuticals Holding
13.24.1 Shanghai Pharmaceuticals Holding Company Information
13.24.2 Shanghai Pharmaceuticals Holding Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.24.3 Shanghai Pharmaceuticals Holding Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Shanghai Pharmaceuticals Holding Main Business Overview
13.24.5 Shanghai Pharmaceuticals Holding Latest Developments
13.25 Jilin Jian Yisheng Pharmaceutical
13.25.1 Jilin Jian Yisheng Pharmaceutical Company Information
13.25.2 Jilin Jian Yisheng Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.25.3 Jilin Jian Yisheng Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Jilin Jian Yisheng Pharmaceutical Main Business Overview
13.25.5 Jilin Jian Yisheng Pharmaceutical Latest Developments
13.26 Guizhou Yibai Pharmaceutical
13.26.1 Guizhou Yibai Pharmaceutical Company Information
13.26.2 Guizhou Yibai Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.26.3 Guizhou Yibai Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Guizhou Yibai Pharmaceutical Main Business Overview
13.26.5 Guizhou Yibai Pharmaceutical Latest Developments
13.27 CSPC Pharmaceutical Group
13.27.1 CSPC Pharmaceutical Group Company Information
13.27.2 CSPC Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.27.3 CSPC Pharmaceutical Group Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 CSPC Pharmaceutical Group Main Business Overview
13.27.5 CSPC Pharmaceutical Group Latest Developments
13.28 Yabao Pharmaceutical
13.28.1 Yabao Pharmaceutical Company Information
13.28.2 Yabao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.28.3 Yabao Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Yabao Pharmaceutical Main Business Overview
13.28.5 Yabao Pharmaceutical Latest Developments
13.29 Kunming Longjin Pharmaceutical
13.29.1 Kunming Longjin Pharmaceutical Company Information
13.29.2 Kunming Longjin Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.29.3 Kunming Longjin Pharmaceutical Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Kunming Longjin Pharmaceutical Main Business Overview
13.29.5 Kunming Longjin Pharmaceutical Latest Developments
13.30 Yunnan Baiyao
13.30.1 Yunnan Baiyao Company Information
13.30.2 Yunnan Baiyao Traditional Chinese Medicine Injection Product Portfolios and Specifications
13.30.3 Yunnan Baiyao Traditional Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Yunnan Baiyao Main Business Overview
13.30.5 Yunnan Baiyao Latest Developments

14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Traditional Chinese Medicine Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Traditional Chinese Medicine Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Detoxification
Table 4. Major Players of Cardiovascular Disease Medication
Table 5. Major Players of Cerebrovascular Disease Medication
Table 6. Major Players of Anti-tumor Drugs
Table 7. Major Players of Other
Table 8. Global Traditional Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 9. Global Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Table 10. Global Traditional Chinese Medicine Injection Revenue by Type (2021-2026) & ($ million)
Table 11. Global Traditional Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Table 12. Global Traditional Chinese Medicine Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Traditional Chinese Medicine Injection Sale by Application (2021-2026) & (K Units)
Table 14. Global Traditional Chinese Medicine Injection Sale Market Share by Application (2021-2026)
Table 15. Global Traditional Chinese Medicine Injection Revenue by Application (2021-2026) & ($ million)
Table 16. Global Traditional Chinese Medicine Injection Revenue Market Share by Application (2021-2026)
Table 17. Global Traditional Chinese Medicine Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Traditional Chinese Medicine Injection Sales by Company (2021-2026) & (K Units)
Table 19. Global Traditional Chinese Medicine Injection Sales Market Share by Company (2021-2026)
Table 20. Global Traditional Chinese Medicine Injection Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Traditional Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
Table 22. Global Traditional Chinese Medicine Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Traditional Chinese Medicine Injection Producing Area Distribution and Sales Area
Table 24. Players Traditional Chinese Medicine Injection Products Offered
Table 25. Traditional Chinese Medicine Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Traditional Chinese Medicine Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Traditional Chinese Medicine Injection Sales Market Share Geographic Region (2021-2026)
Table 30. Global Traditional Chinese Medicine Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Traditional Chinese Medicine Injection Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Traditional Chinese Medicine Injection Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Traditional Chinese Medicine Injection Sales Market Share by Country/Region (2021-2026)
Table 34. Global Traditional Chinese Medicine Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Traditional Chinese Medicine Injection Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Traditional Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 37. Americas Traditional Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Table 38. Americas Traditional Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Traditional Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 40. Americas Traditional Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 41. APAC Traditional Chinese Medicine Injection Sales by Region (2021-2026) & (K Units)
Table 42. APAC Traditional Chinese Medicine Injection Sales Market Share by Region (2021-2026)
Table 43. APAC Traditional Chinese Medicine Injection Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Traditional Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 45. APAC Traditional Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 46. Europe Traditional Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 47. Europe Traditional Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Traditional Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 49. Europe Traditional Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Traditional Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Traditional Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Traditional Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Traditional Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Traditional Chinese Medicine Injection
Table 55. Key Market Challenges & Risks of Traditional Chinese Medicine Injection
Table 56. Key Industry Trends of Traditional Chinese Medicine Injection
Table 57. Traditional Chinese Medicine Injection Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Traditional Chinese Medicine Injection Distributors List
Table 60. Traditional Chinese Medicine Injection Customer List
Table 61. Global Traditional Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Traditional Chinese Medicine Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Traditional Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Traditional Chinese Medicine Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Traditional Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Traditional Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Traditional Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Traditional Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Traditional Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Traditional Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Traditional Chinese Medicine Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Traditional Chinese Medicine Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Traditional Chinese Medicine Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Traditional Chinese Medicine Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Green Valley Pharma Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 76. Green Valley Pharma Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 77. Green Valley Pharma Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Green Valley Pharma Main Business
Table 79. Green Valley Pharma Latest Developments
Table 80. Changbaishan Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Changbaishan Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 82. Changbaishan Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Changbaishan Pharmaceutical Main Business
Table 84. Changbaishan Pharmaceutical Latest Developments
Table 85. Jemincare Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Jemincare Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 87. Jemincare Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Jemincare Main Business
Table 89. Jemincare Latest Developments
Table 90. Qingfeng Pharmaceutical Group Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Qingfeng Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 92. Qingfeng Pharmaceutical Group Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Qingfeng Pharmaceutical Group Main Business
Table 94. Qingfeng Pharmaceutical Group Latest Developments
Table 95. Buchang Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Buchang Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 97. Buchang Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Buchang Pharmaceutical Main Business
Table 99. Buchang Pharmaceutical Latest Developments
Table 100. Livzon Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Livzon Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 102. Livzon Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Livzon Main Business
Table 104. Livzon Latest Developments
Table 105. ZBD Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. ZBD Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 107. ZBD Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. ZBD Pharmaceutical Main Business
Table 109. ZBD Pharmaceutical Latest Developments
Table 110. Chase Sun Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 111. Chase Sun Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 112. Chase Sun Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Chase Sun Pharmaceutical Main Business
Table 114. Chase Sun Pharmaceutical Latest Developments
Table 115. Wuzhou Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 116. Wuzhou Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 117. Wuzhou Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Wuzhou Pharmaceutical Main Business
Table 119. Wuzhou Pharmaceutical Latest Developments
Table 120. Kanion Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 121. Kanion Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 122. Kanion Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Kanion Pharmaceutical Main Business
Table 124. Kanion Pharmaceutical Latest Developments
Table 125. Harbin Pharmaceutical Group Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 126. Harbin Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 127. Harbin Pharmaceutical Group Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Harbin Pharmaceutical Group Main Business
Table 129. Harbin Pharmaceutical Group Latest Developments
Table 130. Fusen Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 131. Fusen Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 132. Fusen Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Fusen Pharmaceutical Main Business
Table 134. Fusen Pharmaceutical Latest Developments
Table 135. Linbao Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 136. Linbao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 137. Linbao Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Linbao Pharmaceutical Main Business
Table 139. Linbao Pharmaceutical Latest Developments
Table 140. Shineway Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 141. Shineway Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 142. Shineway Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Shineway Pharmaceutical Main Business
Table 144. Shineway Pharmaceutical Latest Developments
Table 145. Shanghai Kaibao Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 146. Shanghai Kaibao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 147. Shanghai Kaibao Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Shanghai Kaibao Pharmaceutical Main Business
Table 149. Shanghai Kaibao Pharmaceutical Latest Developments
Table 150. Shanxi Zhendong Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 151. Shanxi Zhendong Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 152. Shanxi Zhendong Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Shanxi Zhendong Pharmaceutical Main Business
Table 154. Shanxi Zhendong Pharmaceutical Latest Developments
Table 155. Mudanjiang Youbo Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 156. Mudanjiang Youbo Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 157. Mudanjiang Youbo Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Mudanjiang Youbo Pharmaceutical Main Business
Table 159. Mudanjiang Youbo Pharmaceutical Latest Developments
Table 160. Xi'an Shijishengkang Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 161. Xi'an Shijishengkang Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 162. Xi'an Shijishengkang Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Xi'an Shijishengkang Pharmaceutical Main Business
Table 164. Xi'an Shijishengkang Pharmaceutical Latest Developments
Table 165. China Resources Sanjiu Medical & Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 166. China Resources Sanjiu Medical & Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 167. China Resources Sanjiu Medical & Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. China Resources Sanjiu Medical & Pharmaceutical Main Business
Table 169. China Resources Sanjiu Medical & Pharmaceutical Latest Developments
Table 170. Tasly Pharmaceuticals Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 171. Tasly Pharmaceuticals Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 172. Tasly Pharmaceuticals Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Tasly Pharmaceuticals Main Business
Table 174. Tasly Pharmaceuticals Latest Developments
Table 175. Dali Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 176. Dali Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 177. Dali Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Dali Pharmaceutical Main Business
Table 179. Dali Pharmaceutical Latest Developments
Table 180. CONBA Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 181. CONBA Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 182. CONBA Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. CONBA Main Business
Table 184. CONBA Latest Developments
Table 185. Yunnan Biovalley Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 186. Yunnan Biovalley Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 187. Yunnan Biovalley Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. Yunnan Biovalley Pharmaceutical Main Business
Table 189. Yunnan Biovalley Pharmaceutical Latest Developments
Table 190. Shanghai Pharmaceuticals Holding Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 191. Shanghai Pharmaceuticals Holding Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 192. Shanghai Pharmaceuticals Holding Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. Shanghai Pharmaceuticals Holding Main Business
Table 194. Shanghai Pharmaceuticals Holding Latest Developments
Table 195. Jilin Jian Yisheng Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 196. Jilin Jian Yisheng Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 197. Jilin Jian Yisheng Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. Jilin Jian Yisheng Pharmaceutical Main Business
Table 199. Jilin Jian Yisheng Pharmaceutical Latest Developments
Table 200. Guizhou Yibai Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 201. Guizhou Yibai Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 202. Guizhou Yibai Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Guizhou Yibai Pharmaceutical Main Business
Table 204. Guizhou Yibai Pharmaceutical Latest Developments
Table 205. CSPC Pharmaceutical Group Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 206. CSPC Pharmaceutical Group Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 207. CSPC Pharmaceutical Group Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. CSPC Pharmaceutical Group Main Business
Table 209. CSPC Pharmaceutical Group Latest Developments
Table 210. Yabao Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 211. Yabao Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 212. Yabao Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Yabao Pharmaceutical Main Business
Table 214. Yabao Pharmaceutical Latest Developments
Table 215. Kunming Longjin Pharmaceutical Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 216. Kunming Longjin Pharmaceutical Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 217. Kunming Longjin Pharmaceutical Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 218. Kunming Longjin Pharmaceutical Main Business
Table 219. Kunming Longjin Pharmaceutical Latest Developments
Table 220. Yunnan Baiyao Basic Information, Traditional Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 221. Yunnan Baiyao Traditional Chinese Medicine Injection Product Portfolios and Specifications
Table 222. Yunnan Baiyao Traditional Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 223. Yunnan Baiyao Main Business
Table 224. Yunnan Baiyao Latest Developments

List of Figures
Figure 1. Picture of Traditional Chinese Medicine Injection
Figure 2. Traditional Chinese Medicine Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Traditional Chinese Medicine Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Traditional Chinese Medicine Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Traditional Chinese Medicine Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Traditional Chinese Medicine Injection Sales Market Share by Country/Region (2025)
Figure 10. Traditional Chinese Medicine Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Detoxification
Figure 12. Product Picture of Cardiovascular Disease Medication
Figure 13. Product Picture of Cerebrovascular Disease Medication
Figure 14. Product Picture of Anti-tumor Drugs
Figure 15. Product Picture of Other
Figure 16. Global Traditional Chinese Medicine Injection Sales Market Share by Type in 2026
Figure 17. Global Traditional Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Figure 18. Traditional Chinese Medicine Injection Consumed in Hospitals
Figure 19. Global Traditional Chinese Medicine Injection Market: Hospitals (2021-2026) & (K Units)
Figure 20. Traditional Chinese Medicine Injection Consumed in Clinics
Figure 21. Global Traditional Chinese Medicine Injection Market: Clinics (2021-2026) & (K Units)
Figure 22. Global Traditional Chinese Medicine Injection Sale Market Share by Application (2025)
Figure 23. Global Traditional Chinese Medicine Injection Revenue Market Share by Application in 2026
Figure 24. Traditional Chinese Medicine Injection Sales by Company in 2026 (K Units)
Figure 25. Global Traditional Chinese Medicine Injection Sales Market Share by Company in 2026
Figure 26. Traditional Chinese Medicine Injection Revenue by Company in 2026 ($ millions)
Figure 27. Global Traditional Chinese Medicine Injection Revenue Market Share by Company in 2026
Figure 28. Global Traditional Chinese Medicine Injection Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Traditional Chinese Medicine Injection Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Traditional Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 31. Americas Traditional Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 32. APAC Traditional Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 33. APAC Traditional Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 34. Europe Traditional Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 35. Europe Traditional Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Traditional Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Traditional Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 38. Americas Traditional Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 39. Americas Traditional Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 40. Americas Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 41. Americas Traditional Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 42. United States Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Traditional Chinese Medicine Injection Sales Market Share by Region in 2026
Figure 47. APAC Traditional Chinese Medicine Injection Revenue Market Share by Region (2021-2026)
Figure 48. APAC Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 49. APAC Traditional Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 50. China Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. India Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Traditional Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 58. Europe Traditional Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 59. Europe Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 60. Europe Traditional Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 61. Germany Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. France Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Traditional Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Traditional Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Traditional Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 69. Egypt Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Traditional Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Traditional Chinese Medicine Injection in 2026
Figure 75. Manufacturing Process Analysis of Traditional Chinese Medicine Injection
Figure 76. Industry Chain Structure of Traditional Chinese Medicine Injection
Figure 77. Channels of Distribution
Figure 78. Global Traditional Chinese Medicine Injection Sales Market Forecast by Region (2027-2032)
Figure 79. Global Traditional Chinese Medicine Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Traditional Chinese Medicine Injection Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Traditional Chinese Medicine Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Traditional Chinese Medicine Injection Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Traditional Chinese Medicine Injection Revenue Market Share Forecast by Application (2027-2032)